nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyruvic acid—SLC16A1—Methotrexate—multiple sclerosis	0.0298	1	CbGbCtD
Pyruvic acid—SLC16A8—retina—multiple sclerosis	0.0247	0.043	CbGeAlD
Pyruvic acid—SLC16A8—medulla oblongata—multiple sclerosis	0.0178	0.0311	CbGeAlD
Pyruvic acid—SLC16A3—Azacitidine—Cladribine—multiple sclerosis	0.0168	1	CbGdCrCtD
Pyruvic acid—SLC16A8—midbrain—multiple sclerosis	0.0163	0.0284	CbGeAlD
Pyruvic acid—PKLR—cerebellum—multiple sclerosis	0.014	0.0244	CbGeAlD
Pyruvic acid—SLC16A6—medulla oblongata—multiple sclerosis	0.0135	0.0236	CbGeAlD
Pyruvic acid—PDHB—retina—multiple sclerosis	0.013	0.0227	CbGeAlD
Pyruvic acid—PKM—brainstem—multiple sclerosis	0.0129	0.0225	CbGeAlD
Pyruvic acid—SLC16A8—cerebellum—multiple sclerosis	0.0126	0.022	CbGeAlD
Pyruvic acid—PKM—retina—multiple sclerosis	0.0124	0.0217	CbGeAlD
Pyruvic acid—SLC16A4—medulla oblongata—multiple sclerosis	0.0124	0.0217	CbGeAlD
Pyruvic acid—SLC16A6—midbrain—multiple sclerosis	0.0123	0.0215	CbGeAlD
Pyruvic acid—SLC16A6—spinal cord—multiple sclerosis	0.012	0.021	CbGeAlD
Pyruvic acid—SLC16A4—midbrain—multiple sclerosis	0.0114	0.0198	CbGeAlD
Pyruvic acid—SLC16A4—spinal cord—multiple sclerosis	0.0111	0.0193	CbGeAlD
Pyruvic acid—SLC16A8—brain—multiple sclerosis	0.0102	0.0179	CbGeAlD
Pyruvic acid—SLC16A6—cerebellum—multiple sclerosis	0.00955	0.0167	CbGeAlD
Pyruvic acid—SLC16A3—brainstem—multiple sclerosis	0.00953	0.0166	CbGeAlD
Pyruvic acid—PDHB—medulla oblongata—multiple sclerosis	0.00942	0.0164	CbGeAlD
Pyruvic acid—SLC16A3—retina—multiple sclerosis	0.0092	0.016	CbGeAlD
Pyruvic acid—PKM—medulla oblongata—multiple sclerosis	0.00899	0.0157	CbGeAlD
Pyruvic acid—SLC16A4—cerebellum—multiple sclerosis	0.00879	0.0153	CbGeAlD
Pyruvic acid—ABAT—brainstem—multiple sclerosis	0.00865	0.0151	CbGeAlD
Pyruvic acid—PDHB—midbrain—multiple sclerosis	0.00861	0.015	CbGeAlD
Pyruvic acid—PDHB—spinal cord—multiple sclerosis	0.0084	0.0147	CbGeAlD
Pyruvic acid—ABAT—retina—multiple sclerosis	0.00835	0.0146	CbGeAlD
Pyruvic acid—PC—medulla oblongata—multiple sclerosis	0.00829	0.0145	CbGeAlD
Pyruvic acid—PKM—spinal cord—multiple sclerosis	0.00801	0.014	CbGeAlD
Pyruvic acid—SLC16A6—brain—multiple sclerosis	0.00776	0.0135	CbGeAlD
Pyruvic acid—PC—midbrain—multiple sclerosis	0.00758	0.0132	CbGeAlD
Pyruvic acid—AGXT2—Nucleotide metabolism—RRM1—multiple sclerosis	0.00746	0.0196	CbGpPWpGaD
Pyruvic acid—PC—spinal cord—multiple sclerosis	0.00739	0.0129	CbGeAlD
Pyruvic acid—SLC16A4—brain—multiple sclerosis	0.00714	0.0125	CbGeAlD
Pyruvic acid—PDHB—nervous system—multiple sclerosis	0.00708	0.0124	CbGeAlD
Pyruvic acid—SLC16A10—Amino acid and oligopeptide SLC transporters—SLC15A2—multiple sclerosis	0.00707	0.0186	CbGpPWpGaD
Pyruvic acid—AGXT2—Amino acid and derivative metabolism—SRM—multiple sclerosis	0.00691	0.0182	CbGpPWpGaD
Pyruvic acid—PDHB—central nervous system—multiple sclerosis	0.00681	0.0119	CbGeAlD
Pyruvic acid—PKM—nervous system—multiple sclerosis	0.00675	0.0118	CbGeAlD
Pyruvic acid—PDHB—cerebellum—multiple sclerosis	0.00666	0.0116	CbGeAlD
Pyruvic acid—SLC16A3—medulla oblongata—multiple sclerosis	0.00665	0.0116	CbGeAlD
Pyruvic acid—PKM—central nervous system—multiple sclerosis	0.0065	0.0113	CbGeAlD
Pyruvic acid—SLC16A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.00646	0.017	CbGpPWpGaD
Pyruvic acid—PKM—cerebellum—multiple sclerosis	0.00635	0.0111	CbGeAlD
Pyruvic acid—SLC16A7—medulla oblongata—multiple sclerosis	0.00634	0.0111	CbGeAlD
Pyruvic acid—PC—nervous system—multiple sclerosis	0.00623	0.0109	CbGeAlD
Pyruvic acid—SLC16A2—medulla oblongata—multiple sclerosis	0.00607	0.0106	CbGeAlD
Pyruvic acid—ABAT—medulla oblongata—multiple sclerosis	0.00603	0.0105	CbGeAlD
Pyruvic acid—PC—central nervous system—multiple sclerosis	0.006	0.0105	CbGeAlD
Pyruvic acid—PC—cerebellum—multiple sclerosis	0.00586	0.0102	CbGeAlD
Pyruvic acid—SLC16A7—midbrain—multiple sclerosis	0.0058	0.0101	CbGeAlD
Pyruvic acid—SLC16A1—retina—multiple sclerosis	0.00559	0.00975	CbGeAlD
Pyruvic acid—SLC16A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.00554	0.0146	CbGpPWpGaD
Pyruvic acid—ABAT—midbrain—multiple sclerosis	0.00551	0.00962	CbGeAlD
Pyruvic acid—SLC16A8—Cell surface interactions at the vascular wall—SELE—multiple sclerosis	0.00549	0.0144	CbGpPWpGaD
Pyruvic acid—SLC16A2—spinal cord—multiple sclerosis	0.00541	0.00945	CbGeAlD
Pyruvic acid—PDHB—brain—multiple sclerosis	0.00541	0.00944	CbGeAlD
Pyruvic acid—ABAT—spinal cord—multiple sclerosis	0.00538	0.00939	CbGeAlD
Pyruvic acid—PKM—brain—multiple sclerosis	0.00516	0.00901	CbGeAlD
Pyruvic acid—SLC16A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.0051	0.0134	CbGpPWpGaD
Pyruvic acid—PKM—Carbohydrate metabolism—GPC5—multiple sclerosis	0.00503	0.0132	CbGpPWpGaD
Pyruvic acid—SLC16A3—nervous system—multiple sclerosis	0.00499	0.00872	CbGeAlD
Pyruvic acid—SLC16A3—central nervous system—multiple sclerosis	0.00481	0.00839	CbGeAlD
Pyruvic acid—SLC16A7—nervous system—multiple sclerosis	0.00477	0.00832	CbGeAlD
Pyruvic acid—PC—brain—multiple sclerosis	0.00476	0.00831	CbGeAlD
Pyruvic acid—SLC16A8—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.00475	0.0125	CbGpPWpGaD
Pyruvic acid—SLC16A3—cerebellum—multiple sclerosis	0.0047	0.0082	CbGeAlD
Pyruvic acid—PKLR—Developmental Biology—CD24—multiple sclerosis	0.0046	0.0121	CbGpPWpGaD
Pyruvic acid—SLC16A7—central nervous system—multiple sclerosis	0.00459	0.00801	CbGeAlD
Pyruvic acid—SLC16A2—nervous system—multiple sclerosis	0.00456	0.00796	CbGeAlD
Pyruvic acid—ABAT—nervous system—multiple sclerosis	0.00453	0.00791	CbGeAlD
Pyruvic acid—SLC16A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.00451	0.0119	CbGpPWpGaD
Pyruvic acid—ABAT—Neuronal System—KCNA3—multiple sclerosis	0.00449	0.0118	CbGpPWpGaD
Pyruvic acid—SLC16A7—cerebellum—multiple sclerosis	0.00448	0.00783	CbGeAlD
Pyruvic acid—SLC16A2—central nervous system—multiple sclerosis	0.00439	0.00766	CbGeAlD
Pyruvic acid—SLC16A1—Cell surface interactions at the vascular wall—SELPLG—multiple sclerosis	0.00439	0.0115	CbGpPWpGaD
Pyruvic acid—SLC16A1—Cell surface interactions at the vascular wall—CD58—multiple sclerosis	0.00439	0.0115	CbGpPWpGaD
Pyruvic acid—SLC16A1—Cell surface interactions at the vascular wall—MERTK—multiple sclerosis	0.00439	0.0115	CbGpPWpGaD
Pyruvic acid—ABAT—central nervous system—multiple sclerosis	0.00436	0.00762	CbGeAlD
Pyruvic acid—SLC16A2—cerebellum—multiple sclerosis	0.00429	0.00749	CbGeAlD
Pyruvic acid—ABAT—cerebellum—multiple sclerosis	0.00427	0.00744	CbGeAlD
Pyruvic acid—SLC16A10—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—multiple sclerosis	0.00416	0.0109	CbGpPWpGaD
Pyruvic acid—PKLR—Carbohydrate metabolism—GPC5—multiple sclerosis	0.00405	0.0107	CbGpPWpGaD
Pyruvic acid—SLC16A1—medulla oblongata—multiple sclerosis	0.00404	0.00705	CbGeAlD
Pyruvic acid—SLC16A8—Cell surface interactions at the vascular wall—ITGA4—multiple sclerosis	0.00397	0.0104	CbGpPWpGaD
Pyruvic acid—SLC16A7—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.00387	0.0102	CbGpPWpGaD
Pyruvic acid—SLC16A3—brain—multiple sclerosis	0.00382	0.00666	CbGeAlD
Pyruvic acid—PKLR—FOXA2 and FOXA3 transcription factor networks—ALB—multiple sclerosis	0.00375	0.00986	CbGpPWpGaD
Pyruvic acid—SLC16A1—midbrain—multiple sclerosis	0.00369	0.00644	CbGeAlD
Pyruvic acid—SLCO2A1—nervous system—multiple sclerosis	0.00365	0.00636	CbGeAlD
Pyruvic acid—SLC16A7—brain—multiple sclerosis	0.00364	0.00636	CbGeAlD
Pyruvic acid—SLC16A1—spinal cord—multiple sclerosis	0.0036	0.00628	CbGeAlD
Pyruvic acid—SLC16A8—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.0036	0.00947	CbGpPWpGaD
Pyruvic acid—SLC16A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.00357	0.00938	CbGpPWpGaD
Pyruvic acid—SLC16A3—Cell surface interactions at the vascular wall—SELE—multiple sclerosis	0.00354	0.00931	CbGpPWpGaD
Pyruvic acid—SLCO2A1—central nervous system—multiple sclerosis	0.00351	0.00613	CbGeAlD
Pyruvic acid—SLC16A2—brain—multiple sclerosis	0.00349	0.00608	CbGeAlD
Pyruvic acid—ABAT—brain—multiple sclerosis	0.00346	0.00605	CbGeAlD
Pyruvic acid—SLC16A8—Hemostasis—MERTK—multiple sclerosis	0.00342	0.00899	CbGpPWpGaD
Pyruvic acid—SLC16A8—Hemostasis—SELPLG—multiple sclerosis	0.00342	0.00899	CbGpPWpGaD
Pyruvic acid—SLC16A8—Hemostasis—CD58—multiple sclerosis	0.00342	0.00899	CbGpPWpGaD
Pyruvic acid—SLCO2A1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.00338	0.0089	CbGpPWpGaD
Pyruvic acid—PC—Carbohydrate metabolism—GPC5—multiple sclerosis	0.00318	0.00836	CbGpPWpGaD
Pyruvic acid—SLC16A3—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.00306	0.00805	CbGpPWpGaD
Pyruvic acid—SLC16A1—nervous system—multiple sclerosis	0.00303	0.00529	CbGeAlD
Pyruvic acid—SLCO2A1—Transport of vitamins, nucleosides, and related molecules—ALB—multiple sclerosis	0.00301	0.0079	CbGpPWpGaD
Pyruvic acid—SLC16A7—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.00293	0.00772	CbGpPWpGaD
Pyruvic acid—SLC16A1—central nervous system—multiple sclerosis	0.00292	0.0051	CbGeAlD
Pyruvic acid—SLC16A1—cerebellum—multiple sclerosis	0.00285	0.00498	CbGeAlD
Pyruvic acid—SLCO2A1—brain—multiple sclerosis	0.00279	0.00486	CbGeAlD
Pyruvic acid—SLC16A10—cerebellum—multiple sclerosis	0.00277	0.00483	CbGeAlD
Pyruvic acid—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.00276	0.00725	CbGpPWpGaD
Pyruvic acid—SLCO2A1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.00256	0.00675	CbGpPWpGaD
Pyruvic acid—SLC16A3—Cell surface interactions at the vascular wall—ITGA4—multiple sclerosis	0.00256	0.00673	CbGpPWpGaD
Pyruvic acid—SLC16A8—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.00252	0.00661	CbGpPWpGaD
Pyruvic acid—SLC16A8—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.00241	0.00635	CbGpPWpGaD
Pyruvic acid—SLC16A3—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.00232	0.0061	CbGpPWpGaD
Pyruvic acid—SLC16A1—brain—multiple sclerosis	0.00232	0.00405	CbGeAlD
Pyruvic acid—SLC16A3—Hemostasis—CD58—multiple sclerosis	0.0022	0.0058	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—MERTK—multiple sclerosis	0.0022	0.0058	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—SELPLG—multiple sclerosis	0.0022	0.0058	CbGpPWpGaD
Pyruvic acid—SLC16A8—Hemostasis—PLEK—multiple sclerosis	0.00211	0.00556	CbGpPWpGaD
Pyruvic acid—SLC16A7—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.00205	0.00539	CbGpPWpGaD
Pyruvic acid—PDHB—Metabolism—SRM—multiple sclerosis	0.00197	0.00518	CbGpPWpGaD
Pyruvic acid—SLC16A7—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.00197	0.00517	CbGpPWpGaD
Pyruvic acid—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.00193	0.00507	CbGpPWpGaD
Pyruvic acid—SLC16A1—Cell surface interactions at the vascular wall—SELE—multiple sclerosis	0.00191	0.00502	CbGpPWpGaD
Pyruvic acid—SLC16A10—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.00186	0.00489	CbGpPWpGaD
Pyruvic acid—PKM—Metabolism—SRM—multiple sclerosis	0.00185	0.00487	CbGpPWpGaD
Pyruvic acid—SLC16A8—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.00183	0.00481	CbGpPWpGaD
Pyruvic acid—SLCO2A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.00179	0.00471	CbGpPWpGaD
Pyruvic acid—SLCO2A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.00172	0.00452	CbGpPWpGaD
Pyruvic acid—SLC16A1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.00165	0.00435	CbGpPWpGaD
Pyruvic acid—ABAT—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.00164	0.00432	CbGpPWpGaD
Pyruvic acid—SLC16A3—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.00162	0.00426	CbGpPWpGaD
Pyruvic acid—SLC16A3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.00156	0.00409	CbGpPWpGaD
Pyruvic acid—PKLR—Developmental Biology—PRNP—multiple sclerosis	0.00152	0.00399	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—SRM—multiple sclerosis	0.00149	0.00392	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—SRM—multiple sclerosis	0.00149	0.00392	CbGpPWpGaD
Pyruvic acid—SLC16A7—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.00149	0.00392	CbGpPWpGaD
Pyruvic acid—SLC16A8—Hemostasis—SELE—multiple sclerosis	0.00149	0.00392	CbGpPWpGaD
Pyruvic acid—SLC16A8—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.00145	0.0038	CbGpPWpGaD
Pyruvic acid—PKM—Disease—GPC5—multiple sclerosis	0.00142	0.00374	CbGpPWpGaD
Pyruvic acid—SLC16A10—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.00141	0.00371	CbGpPWpGaD
Pyruvic acid—PDHB—Metabolism—CYP24A1—multiple sclerosis	0.00139	0.00365	CbGpPWpGaD
Pyruvic acid—PDHB—Metabolism—CYP27B1—multiple sclerosis	0.00139	0.00365	CbGpPWpGaD
Pyruvic acid—SLC16A1—Cell surface interactions at the vascular wall—ITGA4—multiple sclerosis	0.00138	0.00363	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—PLEK—multiple sclerosis	0.00136	0.00358	CbGpPWpGaD
Pyruvic acid—PKM—Metabolism—CYP27B1—multiple sclerosis	0.0013	0.00343	CbGpPWpGaD
Pyruvic acid—PKM—Metabolism—CYP24A1—multiple sclerosis	0.0013	0.00343	CbGpPWpGaD
Pyruvic acid—SLCO2A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.0013	0.00343	CbGpPWpGaD
Pyruvic acid—SLC16A8—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.00128	0.00336	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—SRM—multiple sclerosis	0.00127	0.00334	CbGpPWpGaD
Pyruvic acid—PDHB—Metabolism—GPC5—multiple sclerosis	0.00127	0.00334	CbGpPWpGaD
Pyruvic acid—ABAT—Neuronal System—BCHE—multiple sclerosis	0.00126	0.00331	CbGpPWpGaD
Pyruvic acid—SLC16A1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.00125	0.00329	CbGpPWpGaD
Pyruvic acid—PKM—Metabolism—GPC5—multiple sclerosis	0.00119	0.00314	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—SELPLG—multiple sclerosis	0.00119	0.00313	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—MERTK—multiple sclerosis	0.00119	0.00313	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—CD58—multiple sclerosis	0.00119	0.00313	CbGpPWpGaD
Pyruvic acid—PKLR—Developmental Biology—PTPRC—multiple sclerosis	0.00118	0.0031	CbGpPWpGaD
Pyruvic acid—SLC16A3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.00118	0.0031	CbGpPWpGaD
Pyruvic acid—SLC16A7—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.00118	0.0031	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—SRM—multiple sclerosis	0.00117	0.00308	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—GPC5—multiple sclerosis	0.00115	0.00302	CbGpPWpGaD
Pyruvic acid—SLC16A8—Hemostasis—ITGA4—multiple sclerosis	0.00108	0.00283	CbGpPWpGaD
Pyruvic acid—SLC16A8—Hemostasis—IFNB1—multiple sclerosis	0.00107	0.00281	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—CYP24A1—multiple sclerosis	0.00105	0.00276	CbGpPWpGaD
Pyruvic acid—PDHB—Metabolism—RRM1—multiple sclerosis	0.00105	0.00276	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—CYP24A1—multiple sclerosis	0.00105	0.00276	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—CYP27B1—multiple sclerosis	0.00105	0.00276	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—CYP27B1—multiple sclerosis	0.00105	0.00276	CbGpPWpGaD
Pyruvic acid—SLC16A7—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.00104	0.00274	CbGpPWpGaD
Pyruvic acid—SLCO2A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.00103	0.00271	CbGpPWpGaD
Pyruvic acid—PKM—Metabolism—RRM1—multiple sclerosis	0.000988	0.0026	CbGpPWpGaD
Pyruvic acid—SLC16A10—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000985	0.00259	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—GPC5—multiple sclerosis	0.000961	0.00253	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—GPC5—multiple sclerosis	0.000961	0.00253	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—SRM—multiple sclerosis	0.000961	0.00253	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—SELE—multiple sclerosis	0.000959	0.00252	CbGpPWpGaD
Pyruvic acid—SLC16A10—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000945	0.00249	CbGpPWpGaD
Pyruvic acid—SLC16A3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000932	0.00245	CbGpPWpGaD
Pyruvic acid—PKM—Disease—RPL5—multiple sclerosis	0.000926	0.00243	CbGpPWpGaD
Pyruvic acid—SLCO2A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000911	0.0024	CbGpPWpGaD
Pyruvic acid—SLC16A8—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000906	0.00238	CbGpPWpGaD
Pyruvic acid—PC—Disease—GPC5—multiple sclerosis	0.000901	0.00237	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—CYP24A1—multiple sclerosis	0.000894	0.00235	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—CYP27B1—multiple sclerosis	0.000894	0.00235	CbGpPWpGaD
Pyruvic acid—PKM—Disease—SLC11A1—multiple sclerosis	0.000887	0.00233	CbGpPWpGaD
Pyruvic acid—SLC16A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000875	0.0023	CbGpPWpGaD
Pyruvic acid—SLC16A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.00084	0.00221	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—CYP24A1—multiple sclerosis	0.000825	0.00217	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—CYP27B1—multiple sclerosis	0.000825	0.00217	CbGpPWpGaD
Pyruvic acid—SLC16A3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000824	0.00217	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—GPC5—multiple sclerosis	0.000817	0.00215	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—RRM1—multiple sclerosis	0.000797	0.00209	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—RRM1—multiple sclerosis	0.000797	0.00209	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—GPC5—multiple sclerosis	0.000754	0.00198	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—RPL5—multiple sclerosis	0.000746	0.00196	CbGpPWpGaD
Pyruvic acid—SLC16A7—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000738	0.00194	CbGpPWpGaD
Pyruvic acid—SLC16A8—Hemostasis—IL2RA—multiple sclerosis	0.000735	0.00193	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—PLEK—multiple sclerosis	0.000735	0.00193	CbGpPWpGaD
Pyruvic acid—SLC16A10—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000716	0.00188	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—SLC11A1—multiple sclerosis	0.000715	0.00188	CbGpPWpGaD
Pyruvic acid—PKM—Disease—CD28—multiple sclerosis	0.000708	0.00186	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—ITGA4—multiple sclerosis	0.000694	0.00182	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—IFNB1—multiple sclerosis	0.000689	0.00181	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—RRM1—multiple sclerosis	0.000677	0.00178	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—CYP27B1—multiple sclerosis	0.000677	0.00178	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—CYP24A1—multiple sclerosis	0.000677	0.00178	CbGpPWpGaD
Pyruvic acid—SLCO2A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000645	0.0017	CbGpPWpGaD
Pyruvic acid—SLC16A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000637	0.00167	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—RRM1—multiple sclerosis	0.000625	0.00164	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—GPC5—multiple sclerosis	0.000619	0.00163	CbGpPWpGaD
Pyruvic acid—PDHB—Metabolism—BCHE—multiple sclerosis	0.000604	0.00159	CbGpPWpGaD
Pyruvic acid—PC—Disease—RPL5—multiple sclerosis	0.000586	0.00154	CbGpPWpGaD
Pyruvic acid—SLC16A3—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000584	0.00153	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—CD28—multiple sclerosis	0.000571	0.0015	CbGpPWpGaD
Pyruvic acid—PKM—Metabolism—BCHE—multiple sclerosis	0.000568	0.00149	CbGpPWpGaD
Pyruvic acid—SLC16A10—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000566	0.00149	CbGpPWpGaD
Pyruvic acid—PC—Disease—SLC11A1—multiple sclerosis	0.000561	0.00148	CbGpPWpGaD
Pyruvic acid—SLC16A8—Hemostasis—ALB—multiple sclerosis	0.000532	0.0014	CbGpPWpGaD
Pyruvic acid—PKLR—Developmental Biology—TYK2—multiple sclerosis	0.000528	0.00139	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—SRM—multiple sclerosis	0.000519	0.00137	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—SELE—multiple sclerosis	0.000518	0.00136	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—RRM1—multiple sclerosis	0.000513	0.00135	CbGpPWpGaD
Pyruvic acid—PKM—Disease—CD86—multiple sclerosis	0.000505	0.00133	CbGpPWpGaD
Pyruvic acid—SLC16A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000503	0.00132	CbGpPWpGaD
Pyruvic acid—SLC16A10—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000501	0.00132	CbGpPWpGaD
Pyruvic acid—ABAT—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.00048	0.00126	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—IL2RA—multiple sclerosis	0.000474	0.00125	CbGpPWpGaD
Pyruvic acid—SLC16A8—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.00046	0.00121	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—BCHE—multiple sclerosis	0.000457	0.0012	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—BCHE—multiple sclerosis	0.000457	0.0012	CbGpPWpGaD
Pyruvic acid—PKM—Disease—CCR5—multiple sclerosis	0.000448	0.00118	CbGpPWpGaD
Pyruvic acid—PC—Disease—CD28—multiple sclerosis	0.000448	0.00118	CbGpPWpGaD
Pyruvic acid—SLC16A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000445	0.00117	CbGpPWpGaD
Pyruvic acid—PKM—Disease—HLA-A—multiple sclerosis	0.000437	0.00115	CbGpPWpGaD
Pyruvic acid—SLC16A8—Hemostasis—IL2—multiple sclerosis	0.000431	0.00113	CbGpPWpGaD
Pyruvic acid—PKLR—Developmental Biology—MMP9—multiple sclerosis	0.000416	0.00109	CbGpPWpGaD
Pyruvic acid—PKM—Disease—APOE—multiple sclerosis	0.000408	0.00107	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—CD86—multiple sclerosis	0.000407	0.00107	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—BCHE—multiple sclerosis	0.000389	0.00102	CbGpPWpGaD
Pyruvic acid—SLC16A7—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000375	0.000987	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—ITGA4—multiple sclerosis	0.000375	0.000985	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—IFNB1—multiple sclerosis	0.000372	0.000978	CbGpPWpGaD
Pyruvic acid—PKLR—Developmental Biology—STAT3—multiple sclerosis	0.00037	0.000972	CbGpPWpGaD
Pyruvic acid—PKM—Disease—CD80—multiple sclerosis	0.000369	0.000969	CbGpPWpGaD
Pyruvic acid—ABAT—Neuronal System—MAPK1—multiple sclerosis	0.000368	0.000968	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—CYP24A1—multiple sclerosis	0.000366	0.000962	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—CYP27B1—multiple sclerosis	0.000366	0.000962	CbGpPWpGaD
Pyruvic acid—PDHB—Metabolism—APOE—multiple sclerosis	0.000363	0.000955	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—CCR5—multiple sclerosis	0.000361	0.00095	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—BCHE—multiple sclerosis	0.000359	0.000944	CbGpPWpGaD
Pyruvic acid—SLC16A10—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000355	0.000933	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—HLA-A—multiple sclerosis	0.000352	0.000926	CbGpPWpGaD
Pyruvic acid—PKLR—Developmental Biology—TGFB1—multiple sclerosis	0.000343	0.000901	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—ALB—multiple sclerosis	0.000343	0.000901	CbGpPWpGaD
Pyruvic acid—PKM—Metabolism—APOE—multiple sclerosis	0.000341	0.000898	CbGpPWpGaD
Pyruvic acid—SLC16A8—Hemostasis—TGFB1—multiple sclerosis	0.000336	0.000884	CbGpPWpGaD
Pyruvic acid—PKLR—Developmental Biology—MAPK1—multiple sclerosis	0.000336	0.000884	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—GPC5—multiple sclerosis	0.000334	0.00088	CbGpPWpGaD
Pyruvic acid—SLC16A8—Hemostasis—MAPK1—multiple sclerosis	0.00033	0.000867	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—APOE—multiple sclerosis	0.000329	0.000864	CbGpPWpGaD
Pyruvic acid—SLCO2A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000328	0.000862	CbGpPWpGaD
Pyruvic acid—PKLR—Developmental Biology—TNF—multiple sclerosis	0.00032	0.000842	CbGpPWpGaD
Pyruvic acid—PC—Disease—CD86—multiple sclerosis	0.00032	0.00084	CbGpPWpGaD
Pyruvic acid—SLC16A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000315	0.000829	CbGpPWpGaD
Pyruvic acid—PDHB—Metabolism—POMC—multiple sclerosis	0.000312	0.00082	CbGpPWpGaD
Pyruvic acid—PKM—Disease—TYK2—multiple sclerosis	0.000311	0.000818	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—CD80—multiple sclerosis	0.000297	0.000781	CbGpPWpGaD
Pyruvic acid—SLC16A3—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000297	0.00078	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—BCHE—multiple sclerosis	0.000295	0.000775	CbGpPWpGaD
Pyruvic acid—PKM—Metabolism—POMC—multiple sclerosis	0.000293	0.000771	CbGpPWpGaD
Pyruvic acid—PDHB—Metabolism—ALB—multiple sclerosis	0.000284	0.000748	CbGpPWpGaD
Pyruvic acid—PC—Disease—CCR5—multiple sclerosis	0.000283	0.000745	CbGpPWpGaD
Pyruvic acid—PKM—Disease—CD4—multiple sclerosis	0.000281	0.00074	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—IL2—multiple sclerosis	0.000278	0.000731	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—RRM1—multiple sclerosis	0.000277	0.000729	CbGpPWpGaD
Pyruvic acid—PC—Disease—HLA-A—multiple sclerosis	0.000276	0.000726	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—APOE—multiple sclerosis	0.000275	0.000724	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—APOE—multiple sclerosis	0.000275	0.000724	CbGpPWpGaD
Pyruvic acid—PKM—Metabolism—ALB—multiple sclerosis	0.000267	0.000703	CbGpPWpGaD
Pyruvic acid—PKLR—Developmental Biology—IL6—multiple sclerosis	0.000258	0.000679	CbGpPWpGaD
Pyruvic acid—PC—Disease—APOE—multiple sclerosis	0.000258	0.000678	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—IL2RA—multiple sclerosis	0.000256	0.000673	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—TYK2—multiple sclerosis	0.000251	0.00066	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—POMC—multiple sclerosis	0.000236	0.000622	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—POMC—multiple sclerosis	0.000236	0.000622	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—APOE—multiple sclerosis	0.000234	0.000615	CbGpPWpGaD
Pyruvic acid—PC—Disease—CD80—multiple sclerosis	0.000233	0.000613	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—CD4—multiple sclerosis	0.000227	0.000596	CbGpPWpGaD
Pyruvic acid—PKM—Disease—STAT3—multiple sclerosis	0.000218	0.000573	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—TGFB1—multiple sclerosis	0.000217	0.00057	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—APOE—multiple sclerosis	0.000216	0.000568	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—ALB—multiple sclerosis	0.000216	0.000567	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—ALB—multiple sclerosis	0.000216	0.000567	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—MAPK1—multiple sclerosis	0.000212	0.000559	CbGpPWpGaD
Pyruvic acid—PKM—Disease—MYC—multiple sclerosis	0.000202	0.000532	CbGpPWpGaD
Pyruvic acid—PKM—Disease—TGFB1—multiple sclerosis	0.000202	0.000531	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—POMC—multiple sclerosis	0.000201	0.000529	CbGpPWpGaD
Pyruvic acid—PKM—Disease—MAPK1—multiple sclerosis	0.000198	0.000521	CbGpPWpGaD
Pyruvic acid—PC—Disease—TYK2—multiple sclerosis	0.000197	0.000518	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—POMC—multiple sclerosis	0.000186	0.000488	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—ALB—multiple sclerosis	0.000185	0.000486	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—ALB—multiple sclerosis	0.000183	0.000482	CbGpPWpGaD
Pyruvic acid—SLC16A10—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.00018	0.000474	CbGpPWpGaD
Pyruvic acid—PC—Disease—CD4—multiple sclerosis	0.000178	0.000468	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—APOE—multiple sclerosis	0.000177	0.000466	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—STAT3—multiple sclerosis	0.000176	0.000462	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—ALB—multiple sclerosis	0.000169	0.000445	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—MYC—multiple sclerosis	0.000163	0.000429	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—TGFB1—multiple sclerosis	0.000163	0.000428	CbGpPWpGaD
Pyruvic acid—SLC16A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.00016	0.000421	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—MAPK1—multiple sclerosis	0.00016	0.00042	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—BCHE—multiple sclerosis	0.000159	0.000419	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—POMC—multiple sclerosis	0.000152	0.000401	CbGpPWpGaD
Pyruvic acid—PKM—Disease—IL6—multiple sclerosis	0.000152	0.0004	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—IL2—multiple sclerosis	0.00015	0.000394	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—ALB—multiple sclerosis	0.000139	0.000365	CbGpPWpGaD
Pyruvic acid—PC—Disease—STAT3—multiple sclerosis	0.000138	0.000362	CbGpPWpGaD
Pyruvic acid—PC—Disease—MYC—multiple sclerosis	0.000128	0.000337	CbGpPWpGaD
Pyruvic acid—PC—Disease—TGFB1—multiple sclerosis	0.000128	0.000336	CbGpPWpGaD
Pyruvic acid—PC—Disease—MAPK1—multiple sclerosis	0.000125	0.000329	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—IL6—multiple sclerosis	0.000123	0.000323	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—TGFB1—multiple sclerosis	0.000117	0.000308	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—MAPK1—multiple sclerosis	0.000115	0.000302	CbGpPWpGaD
Pyruvic acid—PC—Disease—IL6—multiple sclerosis	9.63e-05	0.000253	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—APOE—multiple sclerosis	9.58e-05	0.000252	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—POMC—multiple sclerosis	8.23e-05	0.000216	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—ALB—multiple sclerosis	7.5e-05	0.000197	CbGpPWpGaD
